Matches in SemOpenAlex for { <https://semopenalex.org/work/W3130514033> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W3130514033 endingPage "345" @default.
- W3130514033 startingPage "334" @default.
- W3130514033 abstract "Abstract Rearranged during transfection (RET), a neuronal growth factor receptor tyrosine kinase, regulates the development of sympathetic, parasympathetic, motor, and sensory neurons in the enteric nervous system. The intended site of action for GSK3352589 is intestinal tissues. GSK3352589 is an RET kinase inhibitor that was administered in double‐blind, randomized, placebo‐controlled single‐dose (SD) and repeat‐dose (RD) studies in healthy subjects to investigate its safety/tolerability and pharmacokinetics. In the SD study (n = 28), GSK3352589 was dosed from 2 to 400 mg, including a food effect arm (25 mg). In the RD study (n = 40), GSK3352589 was dosed for 14 days with food twice daily from 5 to 200 mg. With single (fed and fasted) and repeat (fed) doses, bioavailability was low and less than dose‐proportional. There was a food effect with 25 mg once daily but may not be clinically relevant. Elimination half‐life was ≥17 hours at SD ≥ 15 mg. Accumulation ratios for C max , AUC t , AUC tau , and AUC 24 after twice‐daily dosing to steady state ranged from 1.2 to 1.8 for all doses except the 200‐mg dose, which had ratios between 1.9 and 2.7. Administration of GSK3352589 after SD and RD was well tolerated with no safety concerns in healthy subjects." @default.
- W3130514033 created "2021-03-01" @default.
- W3130514033 creator A5016284947 @default.
- W3130514033 creator A5030856933 @default.
- W3130514033 creator A5048946147 @default.
- W3130514033 creator A5050132762 @default.
- W3130514033 creator A5075035783 @default.
- W3130514033 creator A5087029944 @default.
- W3130514033 date "2021-02-19" @default.
- W3130514033 modified "2023-10-18" @default.
- W3130514033 title "First‐in‐Human Study for a Selective Rearranged During Transfection Tyrosine Kinase Inhibitor, GSK3352589, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers" @default.
- W3130514033 cites W1971208141 @default.
- W3130514033 cites W1975592885 @default.
- W3130514033 cites W2022898836 @default.
- W3130514033 cites W2026661267 @default.
- W3130514033 cites W2046549547 @default.
- W3130514033 cites W2054950564 @default.
- W3130514033 cites W2059036933 @default.
- W3130514033 cites W2064201279 @default.
- W3130514033 cites W2071674990 @default.
- W3130514033 cites W2166422055 @default.
- W3130514033 cites W2804330402 @default.
- W3130514033 cites W2890419855 @default.
- W3130514033 cites W3107962477 @default.
- W3130514033 doi "https://doi.org/10.1002/cpdd.911" @default.
- W3130514033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33606922" @default.
- W3130514033 hasPublicationYear "2021" @default.
- W3130514033 type Work @default.
- W3130514033 sameAs 3130514033 @default.
- W3130514033 citedByCount "1" @default.
- W3130514033 countsByYear W31305140332022 @default.
- W3130514033 crossrefType "journal-article" @default.
- W3130514033 hasAuthorship W3130514033A5016284947 @default.
- W3130514033 hasAuthorship W3130514033A5030856933 @default.
- W3130514033 hasAuthorship W3130514033A5048946147 @default.
- W3130514033 hasAuthorship W3130514033A5050132762 @default.
- W3130514033 hasAuthorship W3130514033A5075035783 @default.
- W3130514033 hasAuthorship W3130514033A5087029944 @default.
- W3130514033 hasConcept C111113717 @default.
- W3130514033 hasConcept C112705442 @default.
- W3130514033 hasConcept C121608353 @default.
- W3130514033 hasConcept C126322002 @default.
- W3130514033 hasConcept C134018914 @default.
- W3130514033 hasConcept C142724271 @default.
- W3130514033 hasConcept C181389837 @default.
- W3130514033 hasConcept C197934379 @default.
- W3130514033 hasConcept C204787440 @default.
- W3130514033 hasConcept C27081682 @default.
- W3130514033 hasConcept C2777288759 @default.
- W3130514033 hasConcept C2778375690 @default.
- W3130514033 hasConcept C2778820342 @default.
- W3130514033 hasConcept C71924100 @default.
- W3130514033 hasConcept C98274493 @default.
- W3130514033 hasConceptScore W3130514033C111113717 @default.
- W3130514033 hasConceptScore W3130514033C112705442 @default.
- W3130514033 hasConceptScore W3130514033C121608353 @default.
- W3130514033 hasConceptScore W3130514033C126322002 @default.
- W3130514033 hasConceptScore W3130514033C134018914 @default.
- W3130514033 hasConceptScore W3130514033C142724271 @default.
- W3130514033 hasConceptScore W3130514033C181389837 @default.
- W3130514033 hasConceptScore W3130514033C197934379 @default.
- W3130514033 hasConceptScore W3130514033C204787440 @default.
- W3130514033 hasConceptScore W3130514033C27081682 @default.
- W3130514033 hasConceptScore W3130514033C2777288759 @default.
- W3130514033 hasConceptScore W3130514033C2778375690 @default.
- W3130514033 hasConceptScore W3130514033C2778820342 @default.
- W3130514033 hasConceptScore W3130514033C71924100 @default.
- W3130514033 hasConceptScore W3130514033C98274493 @default.
- W3130514033 hasIssue "4" @default.
- W3130514033 hasLocation W31305140331 @default.
- W3130514033 hasLocation W31305140332 @default.
- W3130514033 hasOpenAccess W3130514033 @default.
- W3130514033 hasPrimaryLocation W31305140331 @default.
- W3130514033 hasRelatedWork W1934667138 @default.
- W3130514033 hasRelatedWork W2004325424 @default.
- W3130514033 hasRelatedWork W2037651778 @default.
- W3130514033 hasRelatedWork W2080955156 @default.
- W3130514033 hasRelatedWork W2090169689 @default.
- W3130514033 hasRelatedWork W2400119402 @default.
- W3130514033 hasRelatedWork W2793520024 @default.
- W3130514033 hasRelatedWork W3021369409 @default.
- W3130514033 hasRelatedWork W3087516196 @default.
- W3130514033 hasRelatedWork W4298086959 @default.
- W3130514033 hasVolume "10" @default.
- W3130514033 isParatext "false" @default.
- W3130514033 isRetracted "false" @default.
- W3130514033 magId "3130514033" @default.
- W3130514033 workType "article" @default.